Anti-coagulant [EPC]

5589 reported adverse events

Drugs of this class: ASPIRIN, CITRIC ACID, SODIUM BICARBONATE BIVALIRUDIN ARGATROBAN ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SODIUM CITRATE AND CITRIC ACID MONOHYDRATE ADENOSINUM TRIPHOSPHORICUM DINATRUM, NADIDUM, ARGENTUM NITRICUM, IPECACUANHA, ROBINIA PSEUDOACACIA, SULPHUR, ORIGANUM VULGARE, DUODENUM (SUIS), ESOPHAGUS (SUIS), FUNICULUS UMBILICALIS SUIS, STOMACH (SUIS), NUX VOMICA, COUMARINUM, ERYTHRAEA CENTAURIUM, PANCREATINUM, MURIATICUM ACIDUM, CITRICUM ACIDUM, FORMICUM ACIDUM, SARCOLACTICUM ACIDUM, COENZYME A, PROTEUS (MORGANI) ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE

These side effects are most commonly reported by patients taking drugs of the Anti-coagulant [EPC] class:

#	Side effect	Count
0	CHRONIC KIDNEY DISEASE	719
1	RENAL FAILURE	464
2	ACUTE KIDNEY INJURY	463
3	DRUG INEFFECTIVE	349
4	THROMBOSIS IN DEVICE	291
5	HAEMORRHAGE	265
6	OFF LABEL USE	263
7	END STAGE RENAL DISEASE	252
8	THROMBOSIS	225
9	HEPARIN-INDUCED THROMBOCYTOPENIA	220

See all common reactions for Anti-coagulant [EPC]

Drugs of the Anti-coagulant [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	COAGULATION TIME ABNORMAL	128	0.5079
1	CORONARY ARTERY PERFORATION	29	0.2736
2	IMAGING PROCEDURE ARTIFACT	3	0.2500
3	THROMBOSIS WITH THROMBOCYTOPENIA SYNDROME	3	0.2143
4	CORONARY NO-REFLOW PHENOMENON	5	0.2000
5	STENT OCCLUSION	97	0.1823
6	INTRAPERICARDIAL THROMBOSIS	4	0.1739
7	REPERFUSION INJURY	17	0.1466
8	OESOPHAGEAL INTRAMURAL HAEMATOMA	7	0.1400
9	ARTERIOVENOUS FISTULA, ACQUIRED	2	0.1333

See all enriched reactions for Anti-coagulant [EPC]